A Growing Need for Effective Obesity Management

Obesity and overweight conditions affect more than 70% of American adults, contributing to a cascade of related health issues, including diabetes, cardiovascular disease, and joint disorders. Addressing this epidemic requires innovative approaches—and GLP-1 receptor agonists (GLP-1RAs) are at the forefront of this effort. As of 2024, an estimated 12% of U.S. adults have used GLP-1 medications like Ozempic, Wegovy, or Mounjaro, with 6% currently on these therapies. However, with annual costs often exceeding $1,000 per month, affordability remains a significant barrier for many patients.

The Opportunity in Obesity Care

The weight loss market in the U.S. represents a $100 billion annual opportunity, driven by a population increasingly seeking solutions to achieve healthier lives. By incorporating compounded GLP-1 therapies into your practice, you can not only meet your patients’ needs but also create a valuable revenue stream.

Why Partner with Smith Healthcare Solutions?

Our mission is to empower physicians with effective, accessible solutions for their patients. Here’s what sets us apart and what physicians are enabled to do partnering with us:

1. Deliver Proven Therapies at Affordable Prices: Provide your patients with high-quality compounded versions of GLP-1RA treatments, offering the same efficacy as brand-name options but at a fraction of the cost. Prices start at just $299 per month, making these life-changing therapies accessible to a broader patient base.
2. Provide Comprehensive Patient Support: Our services include access to an encrypted group chat with a clinical pharmacist and specialist, where patients receive personalized dietary plans, recipes, and exercise guidance tailored to their medical histories and goals, ensuring your patients stay on track.
3. Nationwide Reach: With nationwide delivery, you can offer this solution to patients regardless of their location.
4. Unlock Additional Revenue Streams
   Physicians can purchase compounded GLP-1 medications directly from us and resell them to patients, generating additional practice income. This model allows you to benefit financially while enhancing patient care.

Let Smith Healthcare Solutions help you make a difference in your patients’ lives while enhancing your practice’s offerings and profitability.

The Numbers Behind GLP-1 Medications

• Market Reach: More than 12% of adults in the U.S. have used GLP-1 therapies for weight loss or related conditions.
• Cost: The market for GLP-1s has grown dramatically, with total spending in 2023 exceeding $15 billion due to high list prices and growing demand.
• Outcomes: Patients on GLP-1s experience significant improvements in weight management and related health outcomes, often reducing long-term healthcare costs.

What GLP-1RA Medications Offer Your Patients

GLP-1 receptor agonists (GLP-1RAs) have revolutionized obesity treatment by delivering consistent and sustainable weight loss. These medications:

• Mimic natural hormones to regulate appetite and improve blood sugar control.
• Help patients lose up to 15% of their body weight when combined with lifestyle interventions.
• Support better outcomes for patients with co-morbidities such as Type 2 diabetes, hypertension, and hyperlipidemia.

Our compounded GLP-1RA medications offer the same efficacy as brand-name versions — at a fraction of the cost. With starting prices at just $299/month, your patients will have access to life-changing treatment that’s accessible and sustainable.

The U.S. Weight Loss Market: A Growing Opportunity

The demand for weight loss solutions continues to rise as obesity rates climb. Consider the potential:

• The U.S. weight loss market generates more than $75 billion annually and is projected to grow steadily.
• Over 108 million Americans are on a weight loss program each year.
• As obesity-related conditions continue to impact health outcomes, patients are increasingly seeking medically supervised weight loss programs.

By offering compounded GLP-1RA medications, you position your practice as a leader in this high-demand market.

Seize the Opportunity Today

With the obesity epidemic escalating and GLP-1 therapies in high demand, there has never been a better time to incorporate Smith Healthcare Solutions LLC into your practice. Together, we can improve patient outcomes and position your practice as a leader in weight loss management.

Contact us to learn how we can support your practice and patients with affordable, effective weight loss solutions.